Floating Button
Home Ey EY Entrepreneur Of The Year 2021 Awards Singapore

A desire to improve and save lives through preventive healthcare

Amala Balakrishner
Amala Balakrishner • 9 min read
A desire to improve and save lives through preventive healthcare
Founders of biotech company MiRXES were working on the PCR technology well before Covid-19 struck
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Founders of biotech company MiRXES were working on the PCR technology well before Covid-19 struck

Apart from the terms ART, MCO, PPE and WFH plus many others, the Covid-19 pandemic has acquainted the world with the acronym of another medical term: Polymerase Chain Reaction (PCR) test. PCR tests are typically administered to detect genetic material from specific organisms, such as the Sars-Cov 2 virus.

Interestingly, Singapore’s very first lab equipped with PCR technologies was set up at the National University of Singapore (NUS) in 2000, well before the pandemic. Being the first in the region meant that many people were perplexed over what PCR tests could do. “Everybody was like, ‘this bunch of people are doing something called PCR. Anybody knows what it is?’,” Zhou Lihan, co-founder and CEO of biotech company MiRXES, recalled in a recent interview with The Edge Singapore.

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2026 The Edge Publishing Pte Ltd. All rights reserved.